| scholarly article | Q13442814 |
| P2093 | author name string | Gatti G | |
| Cruciani M | |||
| Malena M | |||
| Bassetti D | |||
| Miletich F | |||
| Lazzarini L | |||
| Mengoli C | |||
| Graziani MS | |||
| Cazzadori A | |||
| P2860 | cites work | Twice-weekly dapsone for primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1 infection: efficacy, safety and pharmacokinetic data | Q30676377 |
| Pharmacokinetics and safety of weekly dapsone and dapsone plus pyrimethamine for prevention of pneumocystis pneumonia | Q33754929 | ||
| Pharmacokinetics of dapsone in human immunodeficiency virus-infected children | Q35114401 | ||
| Population pharmacokinetics of dapsone administered biweekly to human immunodeficiency virus-infected patients. | Q35129919 | ||
| Pulmonary disposition of antimicrobial agents: in vivo observations and clinical relevance | Q35447443 | ||
| Method of testing the susceptibility of Pneumocystis carinii to antimicrobial agents in vitro | Q35647976 | ||
| Levels of dapsone and pyrimethamine in serum during once-weekly dosing for prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis | Q35821124 | ||
| A comparison of the effectiveness of three regimens in the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients | Q35910981 | ||
| Immunonephelometric and Immunoturbidimetric Assays for Proteins | Q36599580 | ||
| Oral dapsone versus nebulized pentamidine for Pneumocystis carinii pneumonia prophylaxis: an open randomized prospective trial to assess efficacy and haematological toxicity | Q42146332 | ||
| Efficacy and safety of dapsone prophylaxis against Pneumocystis carinii pneumonia in human immunodeficiency virus-infected children. | Q45774345 | ||
| A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group | Q45784083 | ||
| Dapsone, trimethoprim, and sulfamethoxazole plasma levels during treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome (AIDS). Evidence of drug interactions | Q46312673 | ||
| Randomized trial of dapsone and aerosolized pentamidine for the prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis | Q47634523 | ||
| Thrice-weekly cotrimoxazole is better than weekly dapsone-pyrimethamine for the primary prevention of Pneumocystis carinii pneumonia in HIV-infected patients. | Q54049410 | ||
| Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis | Q58653755 | ||
| Pharmacokinetics of dapsone in children | Q59692451 | ||
| Comparative trial of dapsone versus trimethoprim/sulfamethoxazole for primary prophylaxis of Pneumocystis carinii pneumonia | Q64136144 | ||
| Trimethoprim in normal and pathological human lung tissue | Q67273162 | ||
| Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution | Q68861405 | ||
| Primary prophylaxis for Pneumocystis carinii pneumonia: a randomized trial comparing cotrimoxazole, aerosolized pentamidine and dapsone plus pyrimethamine | Q70584581 | ||
| Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group | Q70674006 | ||
| A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens | Q70859020 | ||
| Four different regimens for prevention of Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients | Q72088908 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dapsone | Q422226 |
| P304 | page(s) | 1077-1081 | |
| P577 | publication date | 1997-05-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Penetration of dapsone into pulmonary lining fluid of human immunodeficiency virus type 1-infected patients | |
| P478 | volume | 41 |
| Q35112823 | Dapsone-induced methemoglobinemia: a dose-related occurrence? |
| Q26827380 | Importance of relating efficacy measures to unbound drug concentrations for anti-infective agents |
| Q37942644 | Penetration of anti-infective agents into pulmonary epithelial lining fluid: focus on antifungal, antitubercular and miscellaneous anti-infective agents |
| Q39558319 | Prevention of infection due to Pneumocystis carinii |
Search more.